4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000018
Chief Financial Officer gave up 2,688 shares (to pay taxes)
- Chief Financial Officer acquired 8,523 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Biller Jonathan · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-18 | Exercise or conversion : show line 1 in the form | +8,523 | 25,641 | D | ||
| 2022-02-22 | Shares withheld for taxes : show line 2 in the form | −2,688 | $29.08 | $78,167 | 22,953 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-18 | Exercise or conversion : show line 3 in the form Performance share units | −8,523 | 8,522 | D |
Loading xslF345X03/wf-form4_164565063350307.xml…